Schedule 13G ownership disclosure

AGILE THERAPEUTICS INC

Security class unavailable · CUSIP: 00847L308

Event date: 2024-06-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
680,000
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000473
Form type
SC 13G
Filer
AGILE THERAPEUTICS INC
CIK
CIK 1261249
Filed
Jul 09, 2024
Reporting period
Jun 26, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub